Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of <scp><i>Helicobacter pylori</i></scp> Infection: A Randomized, Open‐Label, Noninferiority Trial
The 7- and 14-day TTQT efficacies for the first-line treatment of H. pylori infection were comparable, and fewer adverse effects occurred in the 7-day group. This trial has been registered at Clinical Trials.gov (NCT05997433).
Authors
- Qingzhou Kong (ORCID: https://orcid.org/0000-0002-4744-3269)
- Lei Guo (ORCID: https://orcid.org/0000-0003-1624-9604)
- Yan‐Hua Su
- Xinqiang Wang (ORCID: https://orcid.org/0000-0001-5514-8588)
- Ruiqiang Zheng
- Yuting Guo (ORCID: https://orcid.org/0000-0003-4493-051X)
- Haimiao Xu (ORCID: https://orcid.org/0000-0003-1060-0512)
- Y Wang (ORCID: https://orcid.org/0000-0002-5443-1311)
- Keren Zhou (ORCID: https://orcid.org/0000-0003-4671-8838)
- Yang Liu (ORCID: https://orcid.org/0000-0002-0367-8189)
- Wei Geng (ORCID: https://orcid.org/0000-0001-9157-5237)
- Yanqing Li (ORCID: https://orcid.org/0000-0003-0575-0399)
- Hongyu Zhao (ORCID: https://orcid.org/0000-0003-3244-9921)
- Junyan Cao (ORCID: https://orcid.org/0000-0001-9255-0023)
- Yueyue Li (ORCID: https://orcid.org/0000-0001-7042-9695)
- Xueping Nan
- Zhongxue Han
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- The Fourth People's Hospital of Zibo City (CN)
- Zaozhuang Municipal Hospital (CN)
- Linyi People's Hospital (CN)
- Binzhou People's Hospital (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Helicobacter
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/hel.70036
- Citations
- 2
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Fundamental Research Funds for the Central Universities